AA
NFH.WS

AQR Arbitrage’s New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a NFH.WS Stock Holding History

AQR Arbitrage’s Portfolio NFH.WS Stock Details NFH.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-287,956
Closed -$3.3M – 1612
2021
Q4 		$3.3M Buy
287,956
+48,709
+20% +$140K 0.08% 248
2021
Q3 		$706K Hold
239,247
– – 0.02% 550
2021
Q2 		$663K Hold
239,247
– – 0.02% 565
2021
Q1 		$701K Sell
239,247
-1,600
-0.7% -$3.84K 0.03% 480
2020
Q4 		$525K Hold
240,847
– – 0.02% 633
2020
Q3 		$424K Hold
240,847
– – 0.02% 437
2020
Q2 		$328K Hold
240,847
– – 0.01% 398
2020
Q1 		$228K Sell
240,847
-209,153
-46% -$258K 0.01% 434
2019
Q4 		$689K Buy
+450,000
New +$635K 0.01% 325

AQR Arbitrage's NFH.WS Position: Q1 2022 in Review

AQR Arbitrage sold out of New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a (NFH.WS) in Q1 2022, closing a stake of 287,956 shares — an estimated $3.3M sold.

AQR Arbitrage first reported a position in NFH.WS in Q4 2019 and held it in 9 quarters. The position peaked at $3.3M in Q4 2021. 0 funds tracked by Wall St. Rank hold NFH.WS as of Q1 2022.

  • AQR Arbitrage reported no remaining New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position as of Q1 2022 after selling out during the quarter.
  • AQR Arbitrage sold 287,956 New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a shares in Q1 2022, an estimated $3.3M.
  • AQR Arbitrage first reported a position in New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a in Q4 2019 and held it in 9 quarters.
  • AQR Arbitrage's New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a position peaked at $3.3M in Q4 2021.
  • 0 funds tracked by Wall St. Rank held New Frontier Health Corporation Warrants, each whole warrant exercisable for one Ordinary Share at a as of Q1 2022.

Based on AQR Arbitrage's 13F filing for Q1 2022, filed 16 May 2022.